Max W. Richardson

1.7k total citations
24 papers, 927 citations indexed

About

Max W. Richardson is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Max W. Richardson has authored 24 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 15 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Max W. Richardson's work include HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (6 papers). Max W. Richardson is often cited by papers focused on HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (6 papers). Max W. Richardson collaborates with scholars based in United States, France and Austria. Max W. Richardson's co-authors include James L. Riley, Jay Rappaport, Kamel Khalili, Megan Estorninho, John Maher, Jean‐François Zagury, Caroline Hull, Lauren Nickolay, Mark Peakman and Timothy Tree and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Max W. Richardson

24 papers receiving 912 citations

Peers

Max W. Richardson

IMMUN

VIROL

ONCOL

EPIDE

Annette Audigé Switzerland

Sven Létourneau Switzerland

Pedro O. de Campos‐Lima Canada

Benoît Vingert France

Steven E. Kauder United States

Sylvie Beaulieu Canada

J P Lamelin France

Wentao Zhang China

Cindy Morris United States

Selena Viganó Switzerland

Annette Audigé Switzerland

Max W. Richardson

414 ×0.8

IMMUN

275 ×0.8

VIROL

139 ×0.4

ONCOL

247 ×1.0

113 ×0.7

EPIDE

Citations per year, relative to Max W. Richardson Max W. Richardson (= 1×) peers Annette Audigé

Countries citing papers authored by Max W. Richardson

Since Specialization

Citations

This map shows the geographic impact of Max W. Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max W. Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max W. Richardson more than expected).

Fields of papers citing papers by Max W. Richardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max W. Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max W. Richardson. The network helps show where Max W. Richardson may publish in the future.

Co-authorship network of co-authors of Max W. Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Max W. Richardson. A scholar is included among the top collaborators of Max W. Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max W. Richardson. Max W. Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kreinbrink, P.J., et al.. (2021). Intensity Modulated Proton Therapy Better Spares Non-Adjacent Organs and Reduces the Risk of Secondary Malignant Neoplasms in the Treatment of Sinonasal Cancers. Medical dosimetry. 47(2). 117–122. 3 indexed citations

Leibman, Rachel S., Max W. Richardson, Christoph T. Ellebrecht, et al.. (2017). Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. PLoS Pathogens. 13(10). e1006613–e1006613. 94 indexed citations

Hull, Caroline, Lauren Nickolay, Megan Estorninho, et al.. (2017). Generation of human islet-specific regulatory T cells by TCR gene transfer. Journal of Autoimmunity. 79. 63–73. 105 indexed citations

Leslie, George J., Jianbin Wang, Max W. Richardson, et al.. (2016). Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. PLoS Pathogens. 12(11). e1005983–e1005983. 33 indexed citations

Evans, Rebecca A., Mark S. Diamond, Andrew J. Rech, et al.. (2016). Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. JCI Insight. 1(14). 123 indexed citations

Richardson, Max W., Lili Guo, Frances Xin, Xiaolu Yang, & James L. Riley. (2014). Stabilized Human TRIM5α Protects Human T Cells From HIV-1 Infection. Molecular Therapy. 22(6). 1084–1095. 29 indexed citations

Richardson, Max W., et al.. (2012). Kruppel-like Factor 2 Modulates CCR5 Expression and Susceptibility to HIV-1 Infection. The Journal of Immunology. 189(8). 3815–3821. 23 indexed citations

Mukherjee, Rithun, Gabriela Plesa, Scott Sherrill-Mix, et al.. (2010). HIV Sequence Variation Associated With env Antisense Adoptive T-cell Therapy in the hNSG Mouse Model. Molecular Therapy. 18(4). 803–811. 15 indexed citations

Varela‐Rohena, Angel, Carmine Carpenito, Elena Pérez, et al.. (2008). Genetic engineering of T cells for adoptive immunotherapy. Immunologic Research. 42(1-3). 166–181. 51 indexed citations

10.

Richardson, Max W., Virginia Kocieda, Peter Silvera, et al.. (2005). Persistent Anti-Gag, -Nef, and -Rev IgM Levels as Markers of the Impaired Functions of CD4+ T-Helper Lymphocytes During SIVmac251 Infection of Cynomolgus Macaques. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(1). 1–11. 3 indexed citations

11.

Richardson, Max W., Peter Silvera, Jack Greenhouse, et al.. (2004). T-Cell Receptor Excision Circles (TREC) in SHIV 89.6p and SIVmac251 Models of HIV-1 Infection. DNA and Cell Biology. 23(1). 1–13. 12 indexed citations

12.

Richardson, Max W., Virginia Kocieda, Houria Hendel, et al.. (2003). Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. Biomedicine & Pharmacotherapy. 57(1). 4–14. 41 indexed citations

13.

Richardson, Max W., Edward J. Gracely, Houria Hendel, et al.. (2003). T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection. AIDS. 17(6). 915–917. 9 indexed citations

14.

Richardson, Max W., Peter Silvera, Christelle Capini, et al.. (2002). Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat Toxoids in Rhesus Macaques: Induction of Humoral and Cellular Immune Responses. DNA and Cell Biology. 21(9). 637–651. 16 indexed citations

15.

Capini, Christelle, Max W. Richardson, Houria Hendel, et al.. (2001). Autoantibodies to TNFα in HIV-1 infection: prospects for anti-cytokine vaccine therapy. Biomedicine & Pharmacotherapy. 55(1). 23–31. 17 indexed citations

16.

Richardson, Max W., et al.. (2001). Viral latency--the papillomavirus model.. PubMed. 106. 443–51; discussion 452. 53 indexed citations

17.

Richardson, Max W., et al.. (2000). Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection. Biomedicine & Pharmacotherapy. 54(1). 21–31. 26 indexed citations

18.

Croul, Sidney, Max W. Richardson, Carlos Lorenzana, et al.. (1999). Role of HIV-1 Tat and CC Chemokine MIP-1α in the pathogenesis of HIV associated central nervous system disorders. Journal of NeuroVirology. 5(6). 685–694. 43 indexed citations

19.

Leal-Pinto, Edgar, et al.. (1997). Molecular Cloning and Functional Reconstitution of a Urate Transporter/Channel. Journal of Biological Chemistry. 272(1). 617–625. 66 indexed citations

20.

Rappaport, Jay, Max W. Richardson, Paul E. Klotman, Suresh K. Arya, & Gabriele Baier‐Bitterlich. (1995). Inhibition of HIV-1 expression by HIV-2. Journal of Molecular Medicine. 73(12). 583–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact